Ready To Welcome To...
Health Care: Drugs
Genentech Inc (DNA: NYSE)
$94.97 0.22 | 0.23%
03/26/09 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.62 |
| 52 Week High | 1.90 |
| 52 Week Low | 0.61 |
| Avg. Daily Vol. (Mil) | 0.22 |
| Beta (3 year) | 2.21 |
| Share Related Items | |
| Mkt Cap (Mil) | 55.52 |
| Shares Out (Mil) | 89.54 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 7.20 |
| Current Ratio | 7.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 0.82 |
| Price/Cash Flow | -8.30 |
| Per Share Data | |
| Earnings | -0.08 |
| Sales | 0.00 |
| Book Value | 0.75 |
| Cash Flow | -0.07 |
| Business Summary | |
|---|---|
| Dalradian Resources, Inc. is engaged in the acquisition, exploration and development of mineral properties in Northern Ireland and Norway. It primarily focuses on the Curraghinalt mesothermal gold deposit as well as explores silver and base metals. | |
| General Information | |
| 155 Wellington Street West
Suite 2920 Toronto, ON M5V 3H1 |
|
| www.dalradian.com | |
| Industry : Metals & Mining | |
| Sector: Basic Materials | |
| Employees: 34 | |
| CEO: Mr. Patrick Anderson | |
| Short Interest | |
| Current Month (Mil) | 0.02 |
| Previous Month (Mil) | 0.05 |
| Short Interest Ratio (Days) | 0.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -9.90 |
| Return on Investments | -10.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with DNA
- Portfolio NameUser Type
- Userjrobwharram Portfolio 1
- ContributorFast Money's Biopharma Trades
- UserRAPTOR SPRTD 0303091449(SUP...
- UserPrelude
- ContributorBarron's Stock Picks From S...
- UserWalter Sandoval Portfolio 1
- UserBenas
- Userachinfo Portfolio 1
- ContributorCramer's 7 Positive SignsTh...
- ContributorFast Money's Options Activi...
Latest DNA Headlines from TheStreet
- Apple Appoints Levinson Chairman 11.15.11 | 05:11 pm
- What's in a Name? For Stock Tickers, Plenty. 10.12.11 | 08:10 am
- Apple's Jobs, Tech Leaders Meet Obama 02.18.11 | 10:02 am
- IBM Backs Anti-Counterfeiting Startup 06.07.10 | 01:06 pm
- Genentech, Biogen Get FDA Request On Rituxan 11.18.09 | 04:11 pm
- Los Angeles OKs Plan To Use Google Web Services 10.27.09 | 04:10 pm
- Seattle Genetics 3Q Loss Narrows On Partnerships 10.22.09 | 06:10 pm
- FDA Nixes Wider Use Of Rheumatoid Arthritis Drug 10.17.09 | 11:10 am
- Apple Director Levinson Leaves Google's Board 10.12.09 | 10:10 am
- Exxon, Microsoft Recruit Genius Teens at MIT 09.18.09 | 01:09 am
Press Releases for DNA
- Dalradian Resources, Inc. Joins OTCQX - PR Newswire 09.20.12 | 07:09 am
Partner Headlines for DNA
- Monoclonal Antibody Companies Command Premiums - Seeking Alpha 07.12.10 | 08:07 am
- Will Biosimilars Alter Biotech Landscape? - Seeking Alpha 05.03.10 | 05:05 pm
- Google Handing It Out for Free While Microsoft Suffers - SeekingAlpha.com 04.28.10 | 12:04 pm
- Generex's Antigen Express: Creating the Next Generation of Cancer Immunotherapy - SeekingAlpha.com 04.14.10 | 04:04 am
- Jury Finds Pfizer Guilty in Racketeering Case: Biotech's Latest Mishaps - SeekingAlpha.com 03.28.10 | 05:03 am
